All results For patients For health professionals Medical encyclopedia News & articles Internet results

Drug images Click to enlarge

Forest Laboratories, Inc. Reports Fiscal Year 2007 Fourth Quarter Revenues of $885,000,000, Reported EPS Loss of ($0.75) and Adjusted EPS of $0.74*, Excluding the Effect of the Cerexa Acquisition
...income of $23,870,000 which increased 98% from $12,046,000 in the prior year and other contract and miscellaneous income of $252,000. Sales of Lexapro(R) (escitalopram oxalate), an SSRI indicated for the initial and maintenance treatment of major depressive disorder and generalized anxiety disorder...
News & Articles (Drugs.com) · More like this

Forest Laboratories, Inc. Reports Fiscal Year 2009 Fourth Quarter Reported EPS of $0.31 Including $0.45 Per Share Charge Related to the Ongoing United States Attorney's Office Investigation
...the U. S. Attorney's Office for the District of Massachusetts (USAO) into marketing, promotional and other activities primarily in connection with Lexapro(R), Celexa(R) and Levothroid(R). These discussions with the DOJ have not yet concluded, and there can be no assurance as to when they will conclude...
News & Articles (Drugs.com) · More like this

Forest Laboratories, Inc. Reports Fiscal Year 2008 Fourth Quarter Reported EPS of $0.55 Including $0.35 Per Share Charge for Licensing Payment
...income of $31,148,000 which increased 31% from $23,870,000 in the prior year and other contract and miscellaneous income of $2,770,000. Sales of Lexapro(R) (escitalopram oxalate), an SSRI indicated for the initial and maintenance treatment of major depressive disorder and generalized anxiety disorder...
News & Articles (Drugs.com) · More like this

Forest Laboratories, Inc. Reports Q3'08 Diluted Earnings Per Share of $0.96. Raises FY2008 EPS Guidance Range to $3.35-$3.45 Excluding $0.15 per Share Licensing Charge
...15% from $22,577,000 in the year-ago period and other contract and miscellaneous income of $2,481,000. Sales in the quarter included $603,454,000 of Lexapro(R) (escitalopram oxalate), an SSRI indicated for the initial and maintenance treatment of major depressive disorder and generalized anxiety disorder...
News & Articles (Drugs.com) · More like this

United States Files Complaint Against Forest Laboratories for Allegedly Violating the False Claims Act
...against a New York pharmaceutical company for alleged False Claims Act violations arising from the company's marketing the drugs Celexa and Lexapro for unapproved pediatric use and for paying kickbacks to induce physicians to prescribe the drugs. Acting Assistant Attorney General Michael F....
News & Articles (Drugs.com) · More like this

See also: Anxiety, Bipolar Disorder, Depression, Fibromyalgia, Generalized Anxiety Disorder, Premenstrual Dysphoric Disorder, Vulvodynia

Having trouble finding what you want?

• Try browsing our A-Z List of Drug Names or our Medical Encyclopedia.
• Try posting your query on the Drugs.com Community Discussion Boards
• Drug Interactions Checker provides detailed information on drug-drug and drug-food interactions.
• Pill Identifier will help you identify an unknown pill by imprint code or shape/color.
• Image Search is helpful if you want to know what a certain pill looks like.
• News, FDA Approvals or In The Pipeline may help if the drug you are looking for is a new drug.